<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04814290</url>
  </required_header>
  <id_info>
    <org_study_id>No. MD/15.08.50</org_study_id>
    <nct_id>NCT04814290</nct_id>
  </id_info>
  <brief_title>Long-term Follow-up of Living Liver Donors: A Single-center Experience</brief_title>
  <official_title>Long-term Follow-up of Living Liver Donors: A Single-center Experience</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Data on the long-term consequences of living liver donation are scarce. This study examined&#xD;
      clinical, laboratory, and radiological parameters and long-term health-related quality of&#xD;
      life (HRQoL) in 237 living liver donors and 239 matched controls during 48 to 168 months of&#xD;
      postdonation follow-up.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data on the long-term consequences of living liver donation are scarce. This study examined&#xD;
      clinical, laboratory, and radiological parameters and long-term health-related quality of&#xD;
      life (HRQoL) in 237 living liver donors and 239 matched controls during 48 to 168 months of&#xD;
      postdonation follow-up.&#xD;
&#xD;
      We used the 36-item short-form health survey (short form-36 health survey, version 1&#xD;
      [SF-36]). The scores for the 4 following subscales were higher in nondonors than in donors:&#xD;
      physical functioning (P = 0.009), role limitations due to physical health (P = 0.002),&#xD;
      energy/fatigue (P &lt; 0.001), and bodily pain (P &lt; 0.001). The scores on the 8 subscales of the&#xD;
      SF-36 were higher in donors with living recipients than in donors whose recipients died (P &lt;&#xD;
      0.001). Our results suggest that living donor right hepatectomy is safe and results in a&#xD;
      postdonation HRQoL similar to that of nondonors in those donors whose recipients are healthy,&#xD;
      while donors whose recipients die have a lower HRQoL that is significantly negatively&#xD;
      correlated with the time since recipient death and improves over time.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2004</start_date>
  <completion_date type="Actual">January 1, 2021</completion_date>
  <primary_completion_date type="Actual">May 1, 2014</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>4 Years</target_duration>
  <primary_outcome>
    <measure>health-related quality of life (HRQoL)</measure>
    <time_frame>4 to 16 years of follow up</time_frame>
    <description>health-related quality of life (HRQoL) (36-item short-form health survey, version 1 [SF-36]).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">476</enrollment>
  <condition>Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>living liver donors</arm_group_label>
    <description>cases already underwent hepatectomy for living-donor liver transplantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>matched controls</arm_group_label>
    <description>healthy persons who attended the preoperative clinic while preparing for donation but were rejected because of an ABO blood group mismatch.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>health-related quality of life (HRQoL) (36-item short-form health survey, version 1 [SF-36]).</intervention_name>
    <description>health-related quality of life (HRQoL) (36-item short-form health survey, version 1 [SF-36]).</description>
    <arm_group_label>living liver donors</arm_group_label>
    <arm_group_label>matched controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        237 living liver donors and 239 matched controls.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18-50 years&#xD;
&#xD;
          -  no comorbidities.&#xD;
&#xD;
          -  BMI less than 30 kg/m2.&#xD;
&#xD;
          -  compatible ABO group.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Older than 50 years.&#xD;
&#xD;
          -  Associated comorbidities.&#xD;
&#xD;
          -  Obesity.&#xD;
&#xD;
          -  Noncompatible ABO group.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
  </eligibility>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 22, 2021</study_first_submitted>
  <study_first_submitted_qc>March 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2021</study_first_posted>
  <last_update_submitted>March 22, 2021</last_update_submitted>
  <last_update_submitted_qc>March 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Ahmed Shehta</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Living-donor liver transplantation</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Follow up</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Privacy for liver transplantation unit, mansoura university.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

